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It is well established that autoantibodies against desmoglein 3 and desmoglein 1 (Dsg1) are relevant in the
pathogenesis of pemphigus vulgaris and pemphigus foliaceus, including its endemic form fogo selvagem (FS).
Isolated reports have shown that in certain patients with these diseases, autoantibodies against other
desmosomal cadherins and E-cadherin may also be present. The goal of this investigation was to determine
whether FS patients and normal individuals living in endemic areas possess autoantibodies against other
desmosomal cadherins and E-cadherin. By testing a large number of FS and endemic control sera by ELISA, we
found a consistent and specific autoantibody response against Dsg1 and other keratinocyte cadherins in these
individuals, which is quite different from healthy individuals from the United States (US controls). Overall, the
highest correlations among the autoantibody responses tested were in the endemic controls, followed by FS
patients, and lowest in the US controls. These findings suggest that multiple, perhaps cross-reactive,
keratinocyte cadherins are recognized by FS patients and endemic controls.
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INTRODUCTION
Both nonendemic pemphigus foliaceus (PF) and fogo
selvagem (FS) show subcorneal epidermal blisters and
pathogenic anti-desmoglein 1 (Dsg1) IgG autoantibodies
(Beutner and Jordon, 1964; Beutner et al., 1968; Roscoe
et al., 1985; Stanley et al., 1986a, 1986b; Diaz et al., 1989a).
FS patients usually live in rural areas of certain states of Brazil
where the prevalence of disease is higher than in urban
communities (Diaz et al., 1989b). The disease exhibits a
strong association with the HLA-DRB1*0102, 0404, and
1402 alleles (Moraes et al., 1997). It is thought that an
environmental antigen(s) may trigger FS (Flores et al., 2009).
One of the relevant target antigens in both PF and FS
is the desmosomal cadherin Dsg1 (Stanley et al., 1986a;
Buxton et al., 1993). Desmosomal cadherins are trans-
membrane glycoproteins that are critical components
of the desmosome, one of the keratinocyte intercellular
junctions (Desai et al., 2009). They include the Dsgs
and desmocollins (Dscs), each with well-characterized iso-
forms; four Dsgs (Dsg1–4) and three Dscs (Dsc1–3; Thomason
et al., 2010). Desmosomal cadherins are structurally and
functionally similar to the classic E-cadherin, which is
the molecular component of the adherens junction.
Adherens junctions are structurally located in the interdes-
mosomal regions of the keratinocyte cell surface (Green
et al., 2010).
IgG antidesmosomal autoantibodies from PF and FS sera
are routinely detected by indirect immunofluorescence,
which have been used as a diagnostic test for these diseases
for decades. The application of ELISA techniques using
recombinant human Dsg1 has improved diagnostic accuracy
(Amagai et al., 1999), and has made it possible to test large
numbers of individuals living in communities in which FS is
endemic (Warren et al., 2003; Qaqish et al., 2009). ELISA
studies have also identified IgG4 anti-Dsg1 autoantibodies as
a serological predictor of FS (Warren et al., 2003; Qaqish
et al., 2009). Moreover, anti-Dsg1 autoantibodies of the IgM
(Diaz et al., 2008) and IgE (Qian et al., 2011) class have also
been detected in the sera of a large number of FS patients,
suggesting an ongoing environmental trigger. Although anti-
Dsg1 IgG and IgG4 autoantibodies have been shown to be
pathogenic in PF and FS (Rock et al., 1989), there have been
reports of autoantibody responses to other members of the
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cadherin family of proteins in certain pemphigus phenotypes.
Dsg3 is diagnostic and pathogenically relevant in pemphigus
vulgaris (Amagai et al., 1991), whereas Dsc antigens may be
relevant in IgA pemphigus (Duker et al., 2009) and certain
forms of pemphigus vulgaris (Mao et al., 2010). Autoanti-
bodies against Dsg4 (Nagasaka et al., 2004) and E-cadherin
(Evangelista et al., 2008) have also been described in
pemphigus vulgaris and PF, respectively.
It is accepted that the desmosome, specifically its
structural component Dsg1, is the target of pathogenic IgG4
polyclonal autoantibodies generated by FS patients. The IgG
response in FS is complex and may result from exposure to
environmental antigens and/or to self-Dsg1. Moreover, the
final pathogenic IgG4 response may evolve via phenomena
such as cross-reactivity with other desmosomal cadherins
and/or epitope spreading. The aim of this study, therefore,
was to determine the IgG autoantibody profile for each of the
eight keratinocyte cadherins in a large number of subjects
from three groups, i.e., FS patients, healthy individuals from
the United States (US controls), and healthy individuals living
in an endemic area of FS (endemic controls). We find that
a substantial number of FS patients and endemic controls
possess autoantibodies not only to Dsg1 but to other
keratinocyte cadherins as well. Some of these autoantibody
responses show strong correlations in the FS and endemic
control groups.
RESULTS
Index value distribution and comparison of eight antigen/
antibody systems in FS patients and two healthy control groups
Sera of 101 FS patients, 106 US controls, and 106 endemic
controls were tested for the presence of IgG autoantibodies to
Dsg1, Dsg2, Dsg3, Dsg4, Dsc1, Dsc2, Dsc3, and E-cadherin
by ELISA. The distribution of index values for each antigen/
antibody system is depicted in a box plot format (Figure 1).
Median index values are reported in Table 1. To evaluate for
significant differences, the data were further analyzed using
24 pairwise comparisons (three groups of sera compared with
each other for each of the eight antigen/antibody systems).
A Bonferroni correction was used to adjust for multiple
comparisons among the 24 tests; thus, for an overall a of
0.05, only P-values below 0.05/24¼ 0.0021 are considered
significant (Table 1).
As expected, we find higher anti-Dsg1 index values
in FS patients than in the US controls and endemic controls
(median 108.79 vs. 22.83 and 9.26, respectively;
Po0.0001). The differences are also significant when
comparing index values of FS patients and the US controls
in five of the seven remaining antigen/antibody systems (Dsg4
and Dsc2 were not significant). In addition, the differences
between index values of FS patients and endemic controls are
all significant, except for Dsc2 and E-cadherin responses
(P¼0.4033 and P¼ 0.2524, respectively).
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Figure 1. The distribution of index values among healthy individuals from the United States (US controls), fogo selvagem (FS) patients, and endemic
controls. Dsg1 ELISA index values show the greatest separation of FS patients from both sets of controls (Po0.0001), but show no difference between the
control groups (P¼0.0162). Each box extends from the lower to the upper quartile (25–75%), with the median shown as a thick line within the box. The whiskers
extend away from the box to the most extreme data point, which is no more than 1.5 times the length of the box. Data points beyond the whiskers are
individually marked. Dsc, desmocollin; Dsg, desmoglein.
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Comparison of index values of the US controls and
endemic controls reveals statistically significant differences
for four antigen/antibody systems (Dsg3, Dsg4, Dsc3, and
E-cadherin). There are three antigen/antibody systems in
which the endemic controls have higher index values than
the US controls, i.e., Dsg4 (median 15.59 vs. 47.28;
o0.0001), Dsc3 (median 3.57 vs. 82.00; Po0.0001), and
E-cadherin (median 44.67 vs. 47.47; Po0.0001), and one
in which the index values of the US controls are higher than
those in endemic controls, i.e., Dsg3 (median 3.78 vs.
75.16; Po0.0001). The differences in index values for the
remaining antigen/antibody systems were not significant
(Dsg1, P¼0.0162; Dsg2, P¼ 0.0150; Dsc1, P¼0.1119;
and Dsc2, P¼0.802).
The receiver-operating characteristic of each of the eight
antigen/antibody systems in FS patients and the US controls
To define the relationships of specificity and sensitivity of
each of the eight antigen/antibody systems using the index
values obtained in the FS patients and the US controls, we
generated receiver-operating characteristic (ROC) curves for
each system (Figure 2). The ROC curves were generated by
plotting sensitivity against 1specificity, as the cutoff point is
varied over the entire range of index values from a disease
group (in this case, FS patients) and a negative control group
(the US controls). The estimated area under the curve (AUC)
is a summary of the entire ROC curve and is unaffected by
choice of a cutoff point, as is the case for sensitivity and
specificity. The AUC is interpreted as the probability that a
randomly selected patient will have a higher value than a
randomly selected healthy control for the test in question.
The three highest estimated AUCs are for Dsg1 (0.98, 95%
confidence interval (CI): 0.96–1.0), Dsc3 (0.90, 95% CI:
0.85–0.94), and Dsc1 (0.88, 95% CI: 0.84–0.93). It is noted
that despite the high number of statistically significant
differences found between FS patients and the US controls
as depicted in Table 1, there is significant overlap in the
distribution of index values in many of the antigen/antibody
systems (Figure 1), which is reflected by low AUC values
(Figure 2).
Percentage of serologically positive individuals in FS patients,
endemic controls, and the US controls for each of the eight
antigen/antibody systems tested
For each antigen/antibody system, we selected the cutoff
point that would generate a specificity of 95%, i.e., false-
positive rate of 5% among the US controls (Table 2). We
defined all index values above the cutoff point as positive,
and then determined the percentage of FS patients and
endemic controls testing positive for each antigen/antibody
system (Figure 3). Figure 3 shows the 5% false-positive rate
among the US controls induced by the cutoff point selected.
The FS patients show a high percentage (97%) of individuals
with IgG reactivity to Dsg1. The FS patients also show a high
percentage of individuals who test positive with each of the
remaining seven antigens (B40% for Dsg2, Dsg3, and Dsc1
and B50% for E-cadherin). Lower numbers of positive
patients are found in the Dsg4 (B30%), Dsc2 (B20%), and
Dsc3 (o20%) systems. A high percentage of endemic
controls are also positive for the eight antigens tested:
B55% for E-cadherin, B40% for Dsg1 and Dsc2, B30%
for Dsc1, B28% for Dsg4, and B20% for Dsg2. Lower
percentages of positive individuals are detected in the Dsg3
(B14%) and Dsc3 (B12%).
The correlation of index values of the eight antigen/antibody
systems in FS patients and two healthy control groups
We next explored correlations among the responses to the
eight antigens within each group or population to determine
whether a higher index value to Dsg1 would be predictive of
a higher index value to any of the other antigens within a
particular group. High correlations among the responses
Table 1. Comparison of distributions of index values for the US controls, FS patients, and endemic controls1
Index value medians P-values for comparison of index value distributions
US
controls
FS
patients
Endemic
controls
US controls vs.
FS patients
US controls vs.
endemic controls
FS patients vs.
endemic controls
Dsg1 22.83 108.79 9.26 o0.0001* 0.0162 o0.0001*
Dsg2 5.72 0.73 9.09 o0.0001* 0.015 o0.0001*
Dsg3 3.78 1.21 75.16 0.001* o0.0001* o0.0001*
Dsg4 47.28 39.93 15.59 0.0088 o0.0001* o0.0001*
Dsc1 23.51 0.86 34.13 o0.0001* 0.1119 o0.0001*
Dsc2 16.22 24.65 11.68 0.012 0.802 0.4033
Dsc3 82.00 12.62 3.57 o0.0001* o0.0001* 0.0007*
E-cadh 47.47 39.11 44.67 o0.0001* o0.0001* 0.2524
Abbreviations: Dsc, desmocollin; Dsg, desmoglein; E-cadh, E-cadherin; FS, fogo selvagam.
1The data from which these medians and P-values were derived are depicted in Figure 1. To adjust for multiple comparisons with an overall a of 0.05, only
P-values below 0.05/24=0.0021 are considered statistically significant (marked by an asterisk (*)). The total number of subjects in each group is as follows:
US controls (n=106), FS patients (n=101), and endemic controls (n=106).
Index value medians and P-values for all pairwise comparisons using the Wilcoxon two-sample test are shown.
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might suggest that the same pool of antibodies is responding
to both antigens (cross-reactivity) or that a common stimulus
is inducing both responses to the same magnitude. To
determine whether there was correlation among the index
values of the eight antigen/antibody systems within each
population, scatter plots were created by plotting index
values for one antigen against index values for each of
the remaining antigens. Spearman correlations were then
computed (r value shown in the right lower quadrant of each
panel). As shown in Figure 4a, Dsg1 index values in FS
patients are highly correlated with the Dsc1 (r¼0.77), Dsc3
(r¼0.72), and Dsg4 (r¼0.70) values. Thus, an FS patient
with a high index value to Dsg1 tends to have a high index
value to Dsc1, Dsc3, and Dsg4 as well. There are 28 pairwise
correlations in each population of individuals. As a summary
of these 28 correlations, the average correlation and range
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Figure 2. Receiver-operating characteristic (ROC) curves generated from healthy individuals from the United States (US controls) and fogo selvagem (FS)
patient data. The ROC curve is a scatter plot of sensitivity against 1specificity, as the cutoff point is varied over the entire range of index values.
The area under the curves (AUCs) generated from these curves are shown in the right lower quadrant of each ROC box. The AUCs show that the highest
performing antigen/antibody systems are Dsg1 (0.098), Dsc1 (0.88), and Dsc3 (0.90). Dsc, desmocollin; Dsg, desmoglein.
Table 2. Index value cutoff points selected for the
eight antigen/antibody systems
Antigen Cutoff point1 Sensitivity (%) Specificity (%)
Dsg1 5 96 95
Dsg2 1.2 43 95
Dsg3 5 41 95
Dsg4 0.54 29 95
Dsc1 4 42 95
Dsc2 10 23 95
Dsc3 25 15 95
E-cadh 40 49 95
Abbreviations: Dsc, desmocollin; Dsg, desmoglein; E-cadh, E-cadherin.
1Cutoff points were generated by selecting a set specificity of 95%.
100
FS patients
Endemic controls
US controls
Dsg1 Dsg2 Dsg3 Dsg4 Dsc1 Dsc2 Dsc3 E-cadh
Fr
eq
ue
nc
y 
of
 s
er
ol
og
ica
lly
po
sit
ive
 in
di
vid
ua
ls
80
60
40
20
0
Figure 3. Percentage of serologically positive individuals among fogo
selvagem (FS) patients, endemic controls, and healthy individuals from the
United States (US controls) for each of the eight antigen/antibody systems.
This bar graph represents positive sera as defined by the cutoff point. FS
patients (black bars), endemic controls (gray bars), and the US controls (white
bars) are shown. Dsc, desmocollin; Dsg, desmoglein; E-cadh, E-cadherin.
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were determined for each population of individuals.
On average, the correlation among responses to the eight
antigens in the FS patients is 0.59 (range 0.40–0.88;
Figure 4a), but is lower in the US controls, with an average
of 0.37 (range 0.03–0.74; Figure 4b). In contrast, the corre-
lations among responses to the eight antigens in the endemic
controls are strikingly high, with an average correlation of
0.79 (range 0.55–0.97; Figure 4c).
DISCUSSION
This investigation was undertaken to assess the spectrum
of autoantibody responses to keratinocyte cadherins in
the serum of FS patients and control individuals from the
United States and from a highly endemic area of FS in Brazil.
The three unique groups tested include the following: (1) FS
patients who are already showing the pathogenic auto-
antibody response, perhaps secondary to sensitization to an
environmental antigen(s); (2) normal immunologically naive
individuals from a nonendemic area (i.e., the US control);
and (3) individuals living in a Brazilian endemic region of FS,
which may harbor the putative sensitizing antigen(s). This
latter group may show autoantibody responses against
keratinocyte cadherins that represent a transition between
the previous two groups. A large number of FS and control
sera were tested against the ectodomain of seven desmoso-
mal cadherins and E-cadherin by ELISA. The results show a
consistent and specific autoantibody response against these
cadherins in FS patients and endemic controls. Moreover, the
autoantibody responses to some of these cadherin antigens
are correlated.
Three observations can be drawn from this investigation:
(a) The autoantibody response to the eight antigens in FS
patients, the US controls, and endemic controls are unique
and, in majority of the cases, significantly different in each of
the three groups by 24 pairwise comparisons of the eight
antigen/antibody systems. As expected, the index values of
anti-Dsg1 autoantibodies from FS patients are significantly
higher (Po0.0001) than that from the US controls, producing
an AUC of 0.98 (95% CI: 0.98–1.00). These findings confirm
that the ELISA assays for anti-Dsg1 autoantibodies as reported
by our group (Warren et al., 2000) and others (Amagai et al.,
1999) are reliable, sensitive, and specific, when used to
distinguish FS patients and the US controls.
On comparing the index values of the FS patients and
the endemic controls, we found that all index values are
significantly different, with the exception of Dsc2
(P¼0.4033) and E-cadherin (P¼ 0.2524). The lack of a
significant difference between the index values for Dsc2 and
E-cadherin in FS patients and endemic controls reflects
extensive overlap in the distributions of index values in the
two groups.
Comparison of index values between the US controls and
endemic controls reveals statistically significant differences
for four antigen/antibody systems, Dsg3 (Po0.0001), Dsg4
(Po0.0001), Dsc3 (Po0.0001), and E-cadherin (Po0.0001).
No significant differences are found for Dsg1 (P¼0.0162),
Dsg2 (P¼0.0150), Dsc1 (P¼0.1119), and Dsc2 (P¼0.820).
A reasonable explanation for these differences (or lack of
differences) remains unknown; however, an unsubstantiated
speculation would be that the earliest response in donors
from endemic areas may be mediated by autoantibodies
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Figure 4. Correlation among the antibody responses. (a) Fogo selvagem (FS)
patient, (b) healthy individuals from the United States (US control), and
(c) endemic control antibody response correlations are depicted by index
value scatter plots for each antigen/antibody system against the others.
The Spearman correlation coefficient (r value) for each scatter plot is listed
in the bottom right corner of each plot. Average r values for each antigen/
antibody system against the remaining seven antigen/antibody systems are
listed in the bottom right corner for each antigen. *Po0.05, **Po0.01,
adjusting for multiple comparisons involving 84 P-values. Dsc, desmocollin;
Dsg, desmoglein; E-cadh, E-cadherin.
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against the first group of antigens (Dsg3, Dsg4, Dsc3, and
E-cadherin).
(b) As shown in Figure 2, ROCs of each antigen/antibody
system provide a tool to evaluate the ability of each ELISA to
separate known positive (FS patients) from known negative
(the US controls) individuals across a range of cutoff points.
An AUC of 0.50 indicates that the test is no better than
chance at detecting a positive case, whereas values closer to
1.0 indicate an optimal test. The AUCs of Dsg1 (0.98, CI:
0.98–1.00), Dsc1 (0.88, CI: 0.84–0.930), and Dsc3 (0.90, CI:
0.85–0.95) showed that these ELISAs were the best separators
of FS patients from the US controls. From our data, it is
evident that aside from the Dsg1 ELISA, none of the
remaining seven antigen/antibody ELISA systems would be
useful as a diagnostic test for FS given their relatively low
sensitivity.
ELISA cutoff points were chosen by setting a specificity
of 95% to minimize false positives. Using these cutoffs
(Figure 3), some FS patients tested positive for Dsg1 (97%),
Dsg2 (42%), Dsg3 (41%), Dsc1 (43%), E-cadherin (50%),
Dsg4 (29%), Dsc2 (24%), and Dsc3 (16%). The US controls
show the 5% false-positive rate determined by the selected
specificity. Interestingly, endemic controls show a sizable
number of positive individuals in some of the antigen/antibody
systems, i.e., E-cadherin (56%), Dsg1 (42%), Dsc2 (41%),
Dsg4 (32%), and Dsc1 (31%). These findings suggest the
relevance of the environment surrounding the FS patients and
endemic controls as a source of sensitizing antigen(s) that lead
to the production of these autoantibodies.
(c) Finally, the Spearman correlations between antigen/
antibody systems of the three groups show interesting results.
First, there is low correlation between anti-Dsg1 autoanti-
bodies and any of the seven remaining antigen/antibody
systems in the US controls. In contrast, anti-Dsg1 autoanti-
bodies show strong correlation with Dsc1 and Dsc3
antibodies in FS patients. FS patients exhibit a weaker
correlation between anti-Dsg1 autoantibodies and Dsg4,
Dsc2, and E-cadherin. Endemic controls show striking
correlations between anti-Dsg1 autoantibodies and autoanti-
bodies to Dsg3, Dsg4, Dsc1, Dsc2, Dsc3, and E-cadherin.
The strong correlations seen in endemic controls and FS
patients suggest exposure of these individuals to a common
environmental antigen(s). The antigen(s) may not be available
in environments where the US controls live. We acknowl-
edge that it is difficult to distinguish between environmental
and genetic influences on the autoantibody responses found
in FS patients and endemic controls. Our current studies
need further confirmation by establishing the autoantibody
response of another control group composed of normal
nonendemic Brazilian individuals of the same genetic stock
as those of the Limao Verde endemic controls included in the
current study. Should this new group generate results that
do not overlap those of the endemic controls, then the
environmental etiology of FS would be strengthened.
There may be several explanations for these findings:
(a) the putative environmental antigen(s) may share cross-
reactive epitopes with all the keratinocyte cadherins,
thus triggering independent populations of autoantibo-
dies with specificities to each of the eight antigens;
(b) one or all of the environmentally elicited antikeratino-
cyte cadherin autoantibodies recognize cross-reactive
epitopes on the eight antigens tested because of
structural homologies among these keratinocyte cadher-
ins; and
(c) finally, it is feasible that once an initial autoantibody
response is triggered against one of these cadherins
(primary response), this response may be followed by
autoantibody responses against other keratinocyte cad-
herins by the epitope-spreading mechanism. However,
as these results represent a single time-point observation,
determination of the progression of these responses over
time (as seen in epitope spreading) is not possible with
this data set.
As FS is a rare occurrence, it is likely that other factors
such as the HLA may facilitate the development of this
disease. It is intriguing that anti-E-cadherin autoantibodies are
detected in a large number of individuals from the healthy
endemic control (58%) and FS group (42%), raising the
hypothesis that this primitive molecule may be the initial
cross-reactive antigen. Much work is needed to test these
appealing speculations.
MATERIALS AND METHODS
Sources of sera
A total of 313 sera from adult donors were tested for IgG
autoantibodies against seven desmosomal cadherins and E-cadherin
(101 sera were obtained from FS patients, 106 from healthy controls
from the United States, and 106 from healthy controls living in the
Limao Verde endemic area of Brazil). FS sera were collected from
patients originating from endemic regions, but hospitalized at the
time of drawing blood in three Brazilian hospitals dedicated to treat
these patients: Hospital das Clinicas, Sao Paulo (n¼ 25); Hospital de
Doenc¸as Tropicaes, Goiania (n¼ 31); and Hospital Adventista do
Penfigo, Campo Grande (n¼ 45). The disease was confirmed by
clinical, histological, and immunofluorecent findings. The patients
were in different clinical stages of evolution and were undergoing
systemic steroid therapy. The indirect immunofluorescence studies
showed anti-epidermal intercellular substance autoantibodies in
titers above 1:80 in 94 patients, 1:40 in 5 patients, 1:20 in 1 patient,
and negative in 1 patient. Healthy control sera (defined as complete
absence of cutaneous disease) were obtained from blood bank
donors from the University of North Carolina Blood Bank and
healthy individuals from Limao Verde, Brazil.
The study was approved by the University of North Carolina
Institutional Review Board, and conducted according to the
Declaration of Helsinki Principles. Participants gave their written
informed consent.
Construction and production of recombinant Dsg1, Dsg3, and
E-cadherin antigens
We have previously constructed and expressed the entire extra-
cellular domains of human Dsg1, Dsg3, and E-Cadherin using the
baculovirus system (Ding et al., 1997, 1999; Diaz et al., 2008).
Soluble ectodomains of Dsg1, Dsg3, and E-cadherin were produced
2578 Journal of Investigative Dermatology (2012), Volume 132
G Flores et al.
Autoantibody Profile in Fogo Selvagem
in High Five (Invitrogen, Carlsbad, CA) insect cells by infection with
high-titer recombinant baculovirus stocks. Optimal infection condi-
tions for each recombinant protein were determined by time-course
studies (Liebman et al., 1999). The average protein yield was
10 mgml1 of culture supernatant.
Subcloning of the Dsg2 ectodomain into a baculovirus
expression vector
Complementary DNA encoding the entire human Dsg2 was provi-
ded by Dr M. Mahoney, Jefferson Medical School, and was used to
construct the human Dsg2 ectodomain. The DNA of the Dsg2 ecto-
domain was amplified by PCR using the primer pair of 50-ATCGGG
CGCGGATCCATGGCGCGGAGCCCGGG-30 and 50-ATTCGAAAG
CGGCCGCCTAGTGATGGTGATGATGGTGCAGGCCCACATAGG
AGTCAT-30, and was inserted into pFastBacI (Gibco Life Techno-
logies, Gaithersburg, MD) at BamHI and NotI sites. The coding
region of the construct begins with the endogenous initial Met
followed by a putative signal sequence, as well as an in-frame
His-tag at the C terminus to ensure the secretion, and to facilitate the
purification and detection of the expressed antigen. The resulting
plasmid, pFastBacI-Dsg2 ectodomain, was used to construct into
the Bac-to-Bac system following the manufacturer’s protocol.
Virus stock was prepared by infecting sf9 insect cell in Grace’s
insect cell medium (Invitrogen) containing 10% fetal bovine
serum at 27 oC. Viral titers were determined by end-point dilution
assay in sf9.
Expression of Dsc1, Dsc2, and Dsc3 and Dsg4 recombinant
antigens
The entire complementary DNA of the ectodomain of Dsc1, Dsc2,
and Dsc3 constructed in the pEVmod was provided by Dr Takashi
Hashimoto, Department of Dermatology, Kurume University,
Kurume, Japan. These complementary DNAs were subcloned into
the BD BaculoGold virus vector (BD Biosciences, San Diego, CA).
The Dsg4 extracellular domain already subcloned into the
baculovirus vector was kindly provided by Dr Masayuki Amagai,
Department of Dermatology, Keio University School of Medicine,
Tokyo, Japan.
Production and purification of recombinant E-cadherin and
desmosomal cadherins
His-tagged recombinant forms of Dsg1–4, Dsc1–3, and E-cadherin
ectodomains were generated in the baculovirus expression system
and purified by nickel affinity chromatography using the procedure
previously described (Ding et al., 1997).
ELISA
Immunomicrotiter plates (Costar, Cambridge, MA) were coated with
one of the eight purified desmosomal cadherins (200 ng per well for
Dsc1, Dsg1, Dsg3, and E-cadherin; 100 ng per well for Dsg2 and
Dsc2; and 50ng per well for Dsg4 and Dsc3) at 4 1C overnight. After
washing five times with Tris-buffered saline containing 5mM Caþ þ
and 0.05% Tween-20 (TBS/Caþ þ /T-20), the plate was blocked
with 1% BSA in TBS/Caþ þ /T-20 at room temperature for 1 hour.
The plate was then washed five times and incubated with
duplicate samples of diluted serum for 1 hour at room temperature.
Following washes, the plate was incubated with diluted horseradish
peroxidase–conjugated goat anti-human IgG (Bio-Rad, Hercules, CA)
for 1 hour (1:1,000 for seven desmosomal antigens and 1:1,500 for
E-cadherin). The color development was achieved with the
peroxidase substrate o-phenylenediamine.
An FS serum (1:100 dilution) that produced consistent and
reproducible positive optical density (OD) values for IgG anti-Dsg1
autoantibodies was selected as a positive control. We also selected a
positive serum (1:100 dilution) for Dsg2 (CG14), Dsg3 (Dip), Dsg4
(CG42a), Dsc1, Dsc2, and Dsc3 (CG42a) and E-cadherin (1:200
dilution). A normal human serum from the United States was used
as a negative control throughout. Results were expressed as index
value units as reported by Amagai et al. (1999) and Diaz et al.
(2008). The index value was defined in terms of OD as follows:
Index value ¼ ðTest sampleODÞ  ðNegative controlODÞðPositive controlODÞ  ðNegative controlODÞ100
Negative index values occur when the test sample OD is less
than the negative control OD.
As a reference, we provide the average ODs of duplicate tests of
negative and positive control sera used to generate index values:
Dsg1 (negative 0.81, positive 1.60), Dsg2 (negative 0.48, positive
1.92), Dsg3 (negative 1.39, positive 2.55), Dsg4 (negative 0.78,
positive 2.45), Dsc1 (negative 1.76, positive 3.16), Dsc2 (negative
1.65, positive 3.25), Dsc3 (negative 0.68, positive 2.70), and
E-cadherin (negative 0.17, positive 1.36).
Statistical analysis
Nonparametric methods (DeLong et al., 1988) were used for
the estimation and testing of ROC curves (Hanley and McNeil,
1982) and AUCs. Spearman correlation was used to assess the
strength of correlation among the various measures. The R software
(R Development Core Team, 2011), version 2.13.0, was used to
generate the graphs. The data analysis was performed using the SAS
software. Copyright, SAS Institute. SAS and all other SAS Institute
product or service names are registered trademarks or trademarks
of SAS Institute, Cary, NC.
The Wilcoxon rank sum test (Hollander and Wolfe, 1999) is a
statistical hypothesis test of equality of two distributions (the
distributions in the two groups). Briefly, the test is performed by
pooling the two samples into one sample of n observations, ranking
the values from smallest (rank¼ 1) to largest (rank¼ n), computing
the mean rank in each group, and then comparing the mean ranks
in a formal statistical manner. It is somewhat similar in spirit to the
two-sample t-test, but it only takes the ordering of the observations
into account, not their actual magnitude. Assumption of normal
distributions is not required.
Adjustment for multiple comparisons controls the overall type-I
error when a large number of hypothesis tests are performed. For
example, when 20 hypothesis tests are performed at the 0.05 level
each, and all 20 null hypotheses are in fact true, on average, one test
turns out statistically significant (Po0.05), and the probability of one
or more significant tests is larger than 0.05, and can be much larger.
In fact, if the 20 tests are independent, there is a 64% chance
of at least one test showing a significant result when all 20 null
hypotheses are true. Controlling the overall type-I error guarantees
that the probability of one or more significant findings (Po0.05),
when all 20 null hypotheses are in fact true, is 0.05 or less. The
Bonferroni method achieves that control by performing each test at
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the 0.05/20¼ 0.0025 level, i.e, the overall type-I error is divided by
the number of tests. The method does not require the tests to be
independent (Farcomeni, 2008).
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